Preclinical Alzheimers Disease (AD)
Showing 1 - 25 of >10,000
The Swedish BioFINDER - Preclinical AD Study
Recruiting
- Alzheimer Disease
- +2 more
- Plasma tau
- +4 more
-
Malmö, SwedenSkåne University Hospital
Nov 8, 2023
Database to Investigate Blood-Based and Digital Biomarkers in
Recruiting
- Alzheimer Disease
- +5 more
- Biomarker Data Collection
-
Aventura, Florida
- +15 more
Sep 21, 2022
Alzheimer's Disease Trial in Colombia (Crenezumab, Placebo)
Active, not recruiting
- Alzheimer's Disease
- Crenezumab
- Placebo
-
Armenia, Colombia
- +3 more
Nov 21, 2022
Alzheimer's Disease Trial in Madison (icosapent ethyl (IPE), gel cap )
Active, not recruiting
- Alzheimer's Disease
- icosapent ethyl (IPE)
- gel cap placebo
-
Madison, WisconsinWilliam S. Middleton Memorial Veterans Hospital, Madison, WI
Jul 23, 2021
Falls: A Marker of Preclinical AD
Enrolling by invitation
- Fall
- Alzheimer Disease
-
Saint Louis, MissouriWashington University School of Medicine
Jun 25, 2021
Alzheimer, Dementia, Dementia Alzheimers Trial in Houston (Care4AD system)
Recruiting
- Alzheimer Disease
- +2 more
- Care4AD system
-
Houston, Texas
- +1 more
Jun 23, 2022
Imaging Biomarkers in Preclinical and Symptomatic AD
Recruiting
- Alzheimer Disease
- [11C] Pittsburgh Compound-B (PIB)
-
Saint Louis, MissouriWashington University School of Medicine
Jun 29, 2021
Alzheimers Disease, Dementia, Alzheimers Disease, Familial Trial in Worldwide (Gantenerumab, Matching Placebo (Gantenerumab))
Suspended
- Alzheimers Disease
- +2 more
- Gantenerumab
- Matching Placebo (Gantenerumab)
-
Birmingham, Alabama
- +34 more
Jan 10, 2023
Cognitive Decline by Neuroimaging Techniques and Application in
Recruiting
- Subjective Cognitive Decline
- Preclinical Alzheimer's Disease
- Neuropsychological scale
-
Beijing, Beijing, ChinaDepartment of Neurolgy,Xuanwu Hospital of Capital Medical Univer
Jun 29, 2021
Alzheimer Trial in Brescia (real-rTMS, sham-rTMS)
Recruiting
- Alzheimer Disease
- real-rTMS
- sham-rTMS
-
Brescia, ItalyIRCCS Centro San Giovanni di Dio Fatebenefratelli
Aug 2, 2023
Dementia Alzheimers Trial in Toronto (CT scan)
Completed
- Dementia Alzheimers
- CT scan
-
Toronto, Ontario, CanadaBaycrest Health Sciences
Feb 28, 2022
Early Alzheimers Disease, Mild Cognitive Impairment Due to AD Trial in Worldwide (PQ912, Placebo)
Active, not recruiting
- Early Alzheimers Disease
- Mild Cognitive Impairment Due to AD
- PQ912
- Placebo
-
Ganderup, Denmark
- +20 more
Dec 23, 2022
Test to Detect Risk of Alzheimer's Disease Pathology
Enrolling by invitation
- Alzheimer Disease
- +3 more
- Tap Talk online program
-
Hobart, Tasmania, AustraliaUniversity of Tasmania
Oct 29, 2023
Alzheimer, Mild Cognitive Impairment Trial in Los Angeles (Brivaracetam)
Not yet recruiting
- Alzheimer Disease
- Mild Cognitive Impairment
-
Los Angeles, CaliforniaMary S. Easton Center for Alzheimer's Research and Care
Jun 1, 2023
Dementia, Dementia Alzheimers Trial in Waco
Recruiting
- Dementia
- Dementia Alzheimers
-
Waco, TexasBirkeland Current
Apr 29, 2021
Renji Alzheimer's Disease Neuroimaging Cohort Study
Enrolling by invitation
- Alzheimer Disease
-
Shanghai, ChinaRenji Hospital,Shanghai Jiao Tong University School of Medicine
Jun 22, 2022
Disease Progression Using Deep Neuro Signatures
Recruiting
- Alzheimer's Disease
- Mild Cognitive Impairment
-
Athens, GreeceNikaia Ag Panteleimon Hospital
Feb 10, 2022
Contributions of mTBI to Neurodegeneration Due to Chronic
Recruiting
- Mild Traumatic Brain Injury
- +2 more
- No Intervention is used for this study but all subjects will be asked to complete EEG testing and an MRI scan.
- No intervention is used for this study but all subjects will be asked to complete a venous blood draw procedure and a lumbar puncture procedure.
-
Boston, MassachusettsVA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
Aug 31, 2021
Aducanumab-avwa in Alzheimer's Disease in the US
Terminated
- Alzheimers Disease
-
Chula Vista, California
- +21 more
Jun 16, 2022
Mild Cognitive Impairment, Cognitive Impairment, Alzheimer Trial in Winston-Salem (Insulin (Humulin® R U-100), Empagliflozin 10
Recruiting
- Mild Cognitive Impairment
- +2 more
- Insulin (Humulin® R U-100)
- +4 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences / Wake Forest School of M
Nov 10, 2021
Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)
Active, not recruiting
- Alzheimer's Disease
- Semorinemab
- +2 more
-
Garden Grove, California
- +48 more
Sep 1, 2022
Early Diagnosis of SCD Based on Radiogenomics
Recruiting
- Alzheimer Disease
- +3 more
- Multiple features extraction
-
Beijing, Beijing, ChinaDepartment of Neurolgy, Xuanwu Hospital of Capital Medical Unive
Jul 12, 2022
Dementias and Microbiota Composition: Is Possible to Revert
Recruiting
- Dementia Alzheimers
- +4 more
- No intervention
- Probiotic supplement
-
Tarragona, SpainDr. Margarita Torrente
Jul 12, 2023